Cabot (NYSE:CBT)‘s stock had its “hold” rating restated by investment analysts at Robert W. Baird in a research report issued on Tuesday. They presently have a $67.00 price objective on the specialty chemicals company’s stock. Robert W. Baird’s price objective would suggest a potential upside of 19.77% from the stock’s previous close.
Other equities analysts have also recently issued research reports about the stock. Jefferies Group restated a “buy” rating and issued a $78.00 price objective on shares of Cabot in a research report on Thursday, February 8th. Northcoast Research set a $75.00 price objective on shares of Cabot and gave the company a “buy” rating in a research report on Monday, February 12th. Zacks Investment Research cut shares of Cabot from a “buy” rating to a “hold” rating in a research report on Monday. SunTrust Banks upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Tuesday, December 19th. Finally, ValuEngine upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $71.57.
CBT stock opened at $55.94 on Tuesday. Cabot has a 12-month low of $50.21 and a 12-month high of $68.63. The stock has a market capitalization of $3,395.07, a price-to-earnings ratio of 16.31, a PEG ratio of 1.35 and a beta of 1.40. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.02 and a current ratio of 1.63.
Cabot (NYSE:CBT) last released its quarterly earnings data on Tuesday, February 6th. The specialty chemicals company reported $0.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.15. Cabot had a net margin of 2.30% and a return on equity of 15.01%. The firm had revenue of $720.00 million for the quarter, compared to analysts’ expectations of $653.54 million. During the same quarter in the previous year, the company earned $0.84 earnings per share. The company’s revenue for the quarter was up 17.8% compared to the same quarter last year. equities analysts predict that Cabot will post 4.06 EPS for the current year.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Allianz Asset Management GmbH increased its position in shares of Cabot by 5.0% during the fourth quarter. Allianz Asset Management GmbH now owns 774,757 shares of the specialty chemicals company’s stock valued at $47,717,000 after buying an additional 36,691 shares during the period. California Public Employees Retirement System increased its position in shares of Cabot by 4.4% during the third quarter. California Public Employees Retirement System now owns 129,381 shares of the specialty chemicals company’s stock valued at $7,219,000 after buying an additional 5,481 shares during the period. New Mexico Educational Retirement Board purchased a new position in shares of Cabot during the fourth quarter valued at about $948,000. First Trust Advisors LP increased its position in shares of Cabot by 14.9% during the fourth quarter. First Trust Advisors LP now owns 259,671 shares of the specialty chemicals company’s stock valued at $15,993,000 after buying an additional 33,764 shares during the period. Finally, Delpha Capital Management LLC purchased a new position in shares of Cabot during the fourth quarter valued at about $340,000. Institutional investors own 87.18% of the company’s stock.
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.